Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Laurus Labs IPO.
June 28, 2024 3:30:00 AM
As part of its IPO plan, Laurus Labs has held talks with around six to eight banks, said the second person cited above, also requesting anonymity. In the case of Lemon Tree, the IPO is likely to ...
Published by : MintJuly 16, 2024 3:30:00 AM
Laurus Labs Ltd share price was down by -0.25% from the previous closing price of ?466.20. Who are peers of Laurus Labs Ltd? The peers of Laurus Labs Ltd are Sun Pharmaceuticals Industries Ltd ...
Published by : Business TodayJuly 18, 2024 3:30:00 AM
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Published by : Wall Street JournalDecember 7, 2016 2:29:00 AM
ALSO READ: Laurus Labs IPO subscribed 28% on Day 1 So far, Capital Small Finance Bank Ltd and Equitas Holdings Ltd have started operations. The Chennai-based Esaf Microfinance has applied for ...
Published by : MintOctober 2, 2020 3:30:00 AM
Shattuck was founded to develop drugs that simultaneously inhibit checkpoints in various cancers while bolstering the body's immune response and ability to act against tumors. Shattuck was founded ...
Published by : TheStreet.comFebruary 8, 2022 2:30:00 AM
While the terms of the deal are under wraps, the acquisition is aimed to aid Pine Lab�s recently launched Plural platform Plural which competes with platforms such as BillDesk, Razorpay, PayU ...
Published by : inc42June 26, 2024 1:29:00 PM
Goldman Sachs has expanded its coverage to the India CRO/CDMO (contract research organization/contract development and manufacturing organization) space as supply diversification ...
Published by : InvestingApril 10, 2024 2:47:00 AM
The PE firm's other investments in the Indian healthcare sector include Meril Life Sciences, MedPlus, Laurus Labs, and Metropolis Healthcare. 2DG has been given emergency approval by the Drugs ...
Published by : health.economictimes.indiatimesJuly 17, 2024 3:31:00 AM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Published by : MorningstarLaurus Labs IPO Listing Date
› Listing Date: Monday, December 19, 2016
› BSE Script Code: 540222
› NSE Symbol: LAURUSLABS
› Listing In: ‘B’ Group of Securities
› ISIN: INE947Q01010
› Issue Price: Rs. 428.00 Per Equity Share
› Face Value: Rs. 10.00 Per Equity Share
Laurus Labs Ltd IPO Allotment Status is now available online.
Laurus Labs Ltd is Hyderabad based pharmaceutical company engaged in the business of manufacturing generic active pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and Hepatitis C. Company also manufacture APIs in oncology and other therapeutic areas.
The Initial Public Offer of Laurus Labs subscribed 4.53 times (1.58 times in retail). Public Issue of Laurus Labs was closed for subscription on Dec 08, 2016.
Laurus Labs Ltd IPO to open on Dec 06, 2016 and close for subscription on Dec 08, 2016. The price band for the issue has been fixed at Rs 426 at lower level and Rs 428 at upper level. The equity shares of the company to be list at BSE and NSE.
Laurus Labs Ltd is entering in the capital markets with an initial public offering, Fresh Issue aggregating up to Rs 300.00 Cr and Offer for Sale of 24,107,440 Equity Shares of Rs 10. The price band for the issue has been fixed at Rs 426 at lower level and Rs 428 at upper level.
Laurus Labs Ltd is Hyderabad based pharmaceutical company. Laurus Labs is in the business of manufacturing generic active pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and Hepatitis C. Company also manufacture APIs in oncology and other therapeutic areas.
The issue opens on Dec 06, 2016 and closes for subscription on Dec 08, 2016. The equity shares of the issue are proposed to be list on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
The Laurus Labs IPO is proposed to open on December 6, 2016. The IPO application ends on December 8, 2016.
Retail investors can apply in the retail or non-institutional investor category from December 6, 2016 to December 8, 2016. The Laurus Labs IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Laurus Labs IPO will open for subscription on December 6, 2016. The public issue will close on December 8, 2016.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
